2m 2m 2m 2m 2m 2m 2m
Aclaris Therap (ACRS)
NASDAQ
$5.30+$0.09 (+1.83%)
Price as of Aug 03, 2026 2:17 PM EDT- $726.3MMarket Cap
- 239.87%1-Year Change
- BiotechnologyIndustry
Aclaris Therap (ACRS)
$5.30+$0.09 (+1.83%)
ACRS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.20 | ||
Change | -$0.12 (-2.26%) | ||
Open | $5.30 | ||
High | $5.34 | ||
Low | $5.09 | ||
Previous Close | $5.32 | ||
Volume | 1,638,335 | ||
30-Day Average Volume | 1,767,764 | ||
1-Week Change | -0.57% | ||
1-Month Change | -1.70% | ||
1-Year Change | 239.87% | ||
3-Year Change | -47.32% | ||
5-Year Change | -65.17% | ||
Fundamentals | |||
Shares Outstanding | 139.7M | ||
Total Assets | $198.7M | ||
Market Cap | $726.3M | ||
Enterprise Value | $697.6M | ||
Period: QTR TTM FY | |||
Revenue | $537,000.00 | ||
Net Income | -$19.8M | ||
Free Cash Flow | -$18.2M | ||
EBIT | -$19.8M | ||
EBITDA | -$19.7M | ||
Net Working Capital | $82.9M | ||
EPS | -$0.15 | ||
Enterprise Value/EBITDA | -35 | ||
Enterprise Value/Revenue | 1,299 | ||
P/B | 5 | ||
P/E | -35 | ||
PEG | -5 | ||
Price/Free Cash Flow | -40 | ||
Price/Operating Cash Flow | -40 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue